JANX

Janux Therapeutics, Inc. - Common Stock (JANX)

About Janux Therapeutics, Inc. - Common Stock (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$19.18

Daily low

$18.32

Price at open

$18.42

52 Week High

$35.34

52 Week Low

$12.12

Market cap

1.1B

Dividend yield

Volume

1.2M

Avg. volume

976,254

P/E ratio

-11.19

Janux Therapeutics, Inc. - Common Stock News